Skip to main content
. 2022 Jul 26;16:2395–2406. doi: 10.2147/DDDT.S366558

Table 3.

The IC50 Values of Free Gemcitabine/Curcumin (GEM/CUR), Human Serum Albumin-Gemcitabine/Curcumin Nanoparticles (HSA-GEM/CUR NPs) and Arginine Glycine Peptide-Human Serum Albumin-Gemcitabine/Curcumin Nanoparticles (RGD-HSA-GEM/CUR NPs) Treated SW1990 Cells (Mean ± SD, n=6)

Formulations SW1990 IC50 (µM)
Free GEM/CUR 51.2±3.24*
HSA-GEM/CUR NPs 18.3±2.33*
RGD-HSA-GEM/CUR NPs 11.1±1.13

Note: *p<0.05 vs the group of RGD-HSA-GEM/CUR NPs.